Evaluation of non-completion of intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer.

Laura Moulton Chambers Ji Son Milena Radeva Robert DeBernardo

Published in: Journal of gynecologic oncology (2020)

In this series, the rate of IP/IV chemotherapy completion is high. Non-home discharge and higher ECOG status following CRS are associated with IP/IV chemotherapy non-completion and should be considered in treatment planning.

Keyphrases

locally advanced
healthcare
squamous cell carcinoma
rectal cancer
chemotherapy induced